MOTHER'S DAY SPECIALS! SHOW ME MORE

Close Notification

Your cart does not contain any items

Principles of Immunotherapy in Breast and Gastrointestinal Cancers

Activity, Mechanisms of Resistance and New Sensitization Strategies

Michele Ghidini, MD, PhD (Medical Oncologist, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, Milano, Italy)

$318.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
23 August 2024
Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance, and New Sensitization Strategies presents updated research findings on immunotherapy, with a special focus on the mechanisms of resistance of those cancer types and how to overcome them.

The book discusses topics such as tumor cell-intrinsic and -extrinsic mechanisms of cancer resistance to immunotherapy; the role of currently available biomarkers; strategies to overcome therapeutic resistance; sensitizing agents for cancer resistance to cell-mediated immunotherapy; and immunotherapeutic approaches, mechanisms of resistance, and sensitizing strategies in gastroesophageal and biliopancreatic tumors and colorectal cancer.

It is a valuable resource for researchers, students, and members of the biomedical and medical fields who want to learn more about resistance to immunotherapy and how to overcome it.
Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780443133763
ISBN 10:   044313376X
Series:   Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
Pages:   204
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
1. Tumor cell-intrinsic and extrinsic mechanisms of cancer resistance to immunotherapy 2. Immunotherapy in breast cancer: spotlight on the pivotal role of currently available biomarkers 3. Immunotherapy for breast cancer: new strategies to enhance the patient selection and overcome therapeutic resistance 4. Sensitizing Agents for Cancer Resistance to Cell Mediated Immunotherapy in the GI tract 5. Immunotherapeutic approaches, mechanisms of resistance and sensitizing strategies in gastroesophageal tumors 6. Immunotherapeutic approaches, mechanisms of resistance and sensitizing strategies in biliopancreatic tumors 7. Immunotherapeutic approaches, mechanisms of resistance and sensitizing strategies in colorectal cancer 8. Concluding remarks and future perspectives

Michele Ghidini is a Medical Oncologist working in the Operative Unit of Oncology of Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico in Milan, Italy. He is the one responsible for the clinical and research activities in the field of gastrointestinal tumors. From 2007 till now, he has followed clinical and translational studies mainly concerning biliopancreatic, gastric, and colorectal cancers. Between September 2014 and June 2015, he was a research fellow at the Institute of Cancer Research/Royal Marsden Hospital (London, UK) in the Gastrointestinal Cancer Biology and Genomics Team, and he mainly focused on the role of liquid biopsies in metastatic colorectal cancer. He holds a PhD degree in medical sciences from the University of Parma with a dissertation on the prognostic and predictive roles of liquid biopsies in advanced colorectal carcinoma. He is main author, corresponding or co-author of more of 180 scientific papers indexed on Pubmed and Scopus and works as associate editor for the oncology section of Cell Press journal Helyion. He is member of national and international working groups in the field of oncology such as ESMO, EORTC and AIOM.

See Also